Unlock instant, AI-driven research and patent intelligence for your innovation.

Primer and method for detecting FII gene 3'UTR sequence

A gene and sequence technology, applied in the field of primers for detecting the 3'UTR sequence of FII gene, can solve the problems of multiple mutation types, high mutation rate, and large capacity of FII gene, achieving high specificity and accuracy, simple operation, and sensitivity high effect

Inactive Publication Date: 2016-11-16
南京艾迪康医学检验所有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Protein truncation test (PTT), single-strand conformation polymorphism (SSCP), heteroduplex analysis (HA), denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) have all been applied to FII gene However, all these methods have certain limitations, which limit the detection rate of gene mutations.
Due to the large capacity of the FII gene, many types of mutations, high mutation rate, and scattered distribution of mutation sites, in-depth research on the mutation of the FII gene is prevented, and the fluorescent quantitative PCR method is not applicable.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primer and method for detecting FII gene 3'UTR sequence
  • Primer and method for detecting FII gene 3'UTR sequence
  • Primer and method for detecting FII gene 3'UTR sequence

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Detect the primer of FII gene 3'UTR sequence, comprise: the forward and reverse primer that amplifies coverage detection FII gene 3'UTR sequence; The base sequence of described amplification primer is:

[0034] 20210-F: 5' GCACAGACGGCTGTTCTCTT 3'

[0035] 20210-R: 5' ATAGCACTGGGAGCATTGACGC 3'.

[0036] In the detection, first use the above-mentioned forward and reverse primers to amplify the DNA fragment of the 3'UTR sequence of the FII gene to obtain the amplified product, and then use the above-mentioned sequencing primers to sequence the amplified product to obtain the gene sequence of the amplified product .

[0037] In terms of primer design, each pair of primers designed is located on both sides of the sequence to be amplified, that is, the amplified region includes the entire sequence of the sequence. Although the FII gene has a relatively major mutation site G20210A (on the 3'UTR sequence) in patients with venous thrombosis, there are also many unclear mutatio...

Embodiment 2

[0051] The operation process of blood DNA extraction:

[0052] (1) Genomic DNA extracted from blood:

[0053] 1) Take 500uL of blood and add 1000uL of red blood cell lysate, mix by inversion, and let stand at room temperature for 5 minutes, during which time, invert and mix several times. Centrifuge at 3000rpm for 5min, suck off the supernatant, leave the white blood cell pellet, add 200uL buffer GA, shake until thoroughly mixed.

[0054] 2) Add 20 μl proteinase K solution and mix well.

[0055] 3) Add 200 μl of buffer GB, mix thoroughly by inversion, place at 70°C for 10 minutes, the solution should become clear, and briefly centrifuge to remove water droplets on the inner wall of the tube cap.

[0056] 4) Add 200 μl of absolute ethanol, vortex and mix well for 15 seconds. At this time, flocculent precipitates may appear. Briefly centrifuge to remove water droplets on the inner wall of the tube cap.

[0057] 5) Put the solution and flocculent precipitate obtained in the pr...

Embodiment 3

[0083] Take 24 samples of patients with clinical venous thrombosis, and detect whether there is FII gene mutation in the 24 samples, and the samples are numbered 1-24. The genome was extracted, reagents were prepared and detected according to the methods described in Examples 1 and 2. Add 1 μl of each sample to the detection system PCR reaction solution. At the same time, make positive, negative, and blank controls. Detect with common PCR instrument, the time is 160 minutes.

[0084] Electrophoresis results such as figure 2 As shown, it shows that the primer 20210-F / R of the present invention can effectively amplify blood samples, and the band is single.

[0085] The partial forward sequencing results of the 3'UTR sequence of sample 3 are as follows: image 3 As shown, it is wild type, and no FII mutation was detected.

[0086] The partial forward sequencing results of the 3'UTR sequence of sample 5 are as follows: Figure 4 As shown, it is wild type, and no FII mutatio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a primer and a method for detecting an FII gene 3'UTR sequence. The primer comprises a forward primer, a reverse primer and a sequencing primer which are amplified to cover the FII gene 3'UTR-end sequence. Based on a Sanger sequencing method, the mutations of the FII gene 3'UTR-end sequence of a patient with venous thrombus can be quickly detected by utilizing the sequencing primer, wherein the sequencing primer comprises a main mutation site G20210A positioned at the 3'UTR.

Description

technical field [0001] The invention belongs to the field of life science and biotechnology, in particular to a primer and a method for detecting the 3' UTR sequence of the FII gene. Background technique [0002] Thrombophilia is a state prone to thromboembolism due to hereditary or acquired defects of anticoagulant proteins, coagulation factors, fibrinolytic proteins, etc., or the existence of acquired risk factors. The main clinical manifestation type is venous thromboembolism (VTE) . Thrombophilia can be divided into hereditary thrombophilia and acquired thrombophilia. At present, hereditary risk factors mainly include: coagulation factor V (factor V, FV) Leiden mutation, protein C (PC) deficiency, protein S (PS) Deficiency, prothrombin G20210A (FIIG20210A) gene mutation, antithrombin (AT) deficiency, hyperhomocysteinemia, etc. Prothrombin (prothrombin, PT), coagulation factor II (FII) is the first coagulation factor to be purified and determined for its amino acid sequ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12N15/11
CPCC12Q1/686C12Q1/6869C12Q1/6883C12Q2600/156
Inventor 刘赵玲单战王淑一
Owner 南京艾迪康医学检验所有限公司